| Year |
Citation |
Score |
| 2021 |
Grohmann C, Walker F, Devlin M, Luo MX, Chüeh AC, Doherty J, Vaillant F, Ho GY, Wakefield MJ, Weeden CE, Kamili A, Murray J, Po'uha ST, Weinstock J, Kane SR, ... ... Burgess AW, et al. Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors. Cell Death & Disease. 12: 268. PMID 33712556 DOI: 10.1038/s41419-020-03269-0 |
0.668 |
|
| 2019 |
Foroughi S, Tie J, Gibbs P, Burgess AW. Epidermal growth factor receptor ligands: targets for optimizing treatment of metastatic colorectal cancer. Growth Factors (Chur, Switzerland). 1-17. PMID 31878812 DOI: 10.1080/08977194.2019.1703702 |
0.358 |
|
| 2018 |
Mitchell RA, Luwor RB, Burgess AW. The Epidermal Growth Factor Receptor: Structure-Function Informing the Design of Anticancer Therapeutics. Experimental Cell Research. PMID 30098332 DOI: 10.1016/J.Yexcr.2018.08.009 |
0.357 |
|
| 2018 |
Yip HYK, Tan CW, Hirokawa Y, Burgess AW. Colon organoid formation and cryptogenesis are stimulated by growth factors secreted from myofibroblasts. Plos One. 13: e0199412. PMID 29928021 DOI: 10.1371/Journal.Pone.0199412 |
0.375 |
|
| 2017 |
Parakh S, Gan HK, Parslow AC, Burvenich IJG, Burgess AW, Scott AM. Evolution of anti-HER2 therapies for cancer treatment. Cancer Treatment Reviews. 59: 1-21. PMID 28715775 DOI: 10.1016/J.Ctrv.2017.06.005 |
0.306 |
|
| 2016 |
Yin MX, Catimel B, Gregory M, Condron M, Kapp E, Holmes AB, Burgess AW. Synthesis of an inositol hexakisphosphate (IP6) affinity probe to study the interactome from a colon cancer cell line. Integrative Biology : Quantitative Biosciences From Nano to Macro. PMID 26840369 DOI: 10.1039/C5Ib00264H |
0.326 |
|
| 2016 |
Gan HK, Burgess AW, Parslow AC, Scott AM. Dual targeting of EGFR: ready for prime time? Translational Cancer Research. 5. DOI: 10.21037/8031 |
0.333 |
|
| 2016 |
Gregory M, Catimel B, Yin MX, Condron M, Burgess AW, Holmes AB. Synthesis of a Tethered myo -Inositol (1,3,4,5,6)Pentakisphosphate (IP5) Derivative as a Probe for Biological Studies Synlett. 27: 121-125. DOI: 10.1055/S-0035-1560381 |
0.303 |
|
| 2015 |
Tan CW, Hirokawa Y, Burgess AW. Analysis of Wnt signalling dynamics during colon crypt development in 3D culture. Scientific Reports. 5: 11036. PMID 26087250 DOI: 10.1038/Srep11036 |
0.304 |
|
| 2015 |
Xu Y, Soo P, Walker F, Zhang HH, Redpath N, Tan CW, Nicola NA, Adams TE, Garrett TP, Zhang JG, Burgess AW. LRIG1 extracellular domain: structure and function analysis. Journal of Molecular Biology. 427: 1934-48. PMID 25765764 DOI: 10.1016/J.Jmb.2015.03.001 |
0.32 |
|
| 2015 |
Burgess AW. Growth Factors and Cytokines Reviews in Cell Biology and Molecular Medicine. 1: 104-126. DOI: 10.1002/3527600906.Mcb.200300155.Pub2 |
0.373 |
|
| 2014 |
Aharon R, Janes PW, Burgess AW, Hamza K, Klebaner F, Lackmann M. A mathematical model for eph/ephrin-directed segregation of intermingled cells. Plos One. 9: e111803. PMID 25436892 DOI: 10.1371/Journal.Pone.0111803 |
0.327 |
|
| 2014 |
Phesse TJ, Buchert M, Stuart E, Flanagan DJ, Faux M, Afshar-Sterle S, Walker F, Zhang HH, Nowell CJ, Jorissen R, Tan CW, Hirokawa Y, Eissmann MF, Poh AR, Malaterre J, ... ... Burgess AW, et al. Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regeneration. Science Signaling. 7: ra92. PMID 25270258 DOI: 10.1126/Scisignal.2005411 |
0.309 |
|
| 2014 |
Mouradov D, Sloggett C, Jorissen RN, Love CG, Li S, Burgess AW, Arango D, Strausberg RL, Buchanan D, Wormald S, O'Connor L, Wilding JL, Bicknell D, Tomlinson IP, Bodmer WF, et al. Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. Cancer Research. 74: 3238-47. PMID 24755471 DOI: 10.1158/0008-5472.Can-14-0013 |
0.308 |
|
| 2014 |
Tan CW, Gardiner BS, Hirokawa Y, Smith DW, Burgess AW. Analysis of Wnt signaling β-catenin spatial dynamics in HEK293T cells. Bmc Systems Biology. 8: 44. PMID 24712863 DOI: 10.1186/1752-0509-8-44 |
0.306 |
|
| 2014 |
Kozer N, Barua D, Henderson C, Nice EC, Burgess AW, Hlavacek WS, Clayton AH. Recruitment of the adaptor protein Grb2 to EGFR tetramers. Biochemistry. 53: 2594-604. PMID 24697349 DOI: 10.1021/Bi500182X |
0.326 |
|
| 2014 |
Kumar KK, Burgess AW, Gulbis JM. Structure and function of LGR5: an enigmatic G-protein coupled receptor marking stem cells. Protein Science : a Publication of the Protein Society. 23: 551-65. PMID 24677446 DOI: 10.1002/Pro.2446 |
0.328 |
|
| 2014 |
Burgess AW, Henis YI, Hynes NE, Jovin T, Levitzki A, Pinkas-Kramarski R, Yarden Y. EGF receptor family: twisting targets for improved cancer therapies. Growth Factors (Chur, Switzerland). 32: 74-81. PMID 24641597 DOI: 10.3109/08977194.2014.896355 |
0.387 |
|
| 2014 |
Hirokawa Y, Yip KH, Tan CW, Burgess AW. Colonic myofibroblast cell line stimulates colonoid formation. American Journal of Physiology. Gastrointestinal and Liver Physiology. 306: G547-56. PMID 24481605 DOI: 10.1152/Ajpgi.00267.2013 |
0.34 |
|
| 2014 |
Sieber O, Mouradov D, Sloggett C, Jorissen R, Love C, Li S, Burgess A, Arango D, Strausberg R, Buchanan D, Wormald S, O'Connor L, Wilding J, Bicknell D, Tomlinson I, et al. Abstract 5172: Whole exome mutation landscape of 70 commonly used colorectal cancer cell lines Cancer Research. 74: 5172-5172. DOI: 10.1158/1538-7445.Am2014-5172 |
0.312 |
|
| 2013 |
Elliott KL, Catimel B, Church NL, Coates JL, Burgess AW, Layton MJ, Faux MC. Immunopurification of adenomatous polyposis coli (APC) proteins. Bmc Research Notes. 6: 429. PMID 24156781 DOI: 10.1186/1756-0500-6-429 |
0.308 |
|
| 2013 |
van der Wath RC, Gardiner BS, Burgess AW, Smith DW. Cell organisation in the colonic crypt: a theoretical comparison of the pedigree and niche concepts. Plos One. 8: e73204. PMID 24069177 DOI: 10.1371/Journal.Pone.0073204 |
0.318 |
|
| 2013 |
Kozer N, Barua D, Orchard S, Nice EC, Burgess AW, Hlavacek WS, Clayton AH. Exploring higher-order EGFR oligomerisation and phosphorylation--a combined experimental and theoretical approach. Molecular Biosystems. 9: 1849-63. PMID 23629589 DOI: 10.1039/C3Mb70073A |
0.334 |
|
| 2013 |
Catimel B, Kapp E, Yin MX, Gregory M, Wong LS, Condron M, Church N, Kershaw N, Holmes AB, Burgess AW. The PI(3)P interactome from a colon cancer cell. Journal of Proteomics. 82: 35-51. PMID 23416715 DOI: 10.1016/J.Jprot.2013.01.031 |
0.32 |
|
| 2012 |
Koziolek EJ, Donoghue JF, Bentley JD, Lovrecz G, Dolezal O, Ward CW, Rothacker J, Nice EC, Burgess AW, Hafner M, Johns TG, Adams TE. A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation. Growth Factors (Chur, Switzerland). 30: 310-9. PMID 22856597 DOI: 10.3109/08977194.2012.709516 |
0.383 |
|
| 2012 |
Gan HK, Burgess AW, Clayton AH, Scott AM. Targeting of a conformationally exposed, tumor-specific epitope of EGFR as a strategy for cancer therapy. Cancer Research. 72: 2924-30. PMID 22659454 DOI: 10.1158/0008-5472.Can-11-3898 |
0.347 |
|
| 2012 |
Tan CW, Gardiner BS, Hirokawa Y, Layton MJ, Smith DW, Burgess AW. Wnt signalling pathway parameters for mammalian cells. Plos One. 7: e31882. PMID 22363759 DOI: 10.1371/Journal.Pone.0031882 |
0.328 |
|
| 2011 |
Kozer N, Henderson C, Jackson JT, Nice EC, Burgess AW, Clayton AH. Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells. Physical Biology. 8: 066002. PMID 21946082 DOI: 10.1088/1478-3975/8/6/066002 |
0.351 |
|
| 2011 |
Walker F, Zhang HH, Odorizzi A, Burgess AW. LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines. Plos One. 6: e22733. PMID 21829496 DOI: 10.1371/Journal.Pone.0022733 |
0.348 |
|
| 2011 |
Kozer N, Rothacker J, Burgess AW, Nice EC, Clayton AH. Conformational dynamics in a truncated epidermal growth factor receptor ectodomain. Biochemistry. 50: 5130-9. PMID 21591616 DOI: 10.1021/Bi200095W |
0.32 |
|
| 2011 |
Kozer N, Kelly MP, Orchard S, Burgess AW, Scott AM, Clayton AH. Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers. Biochemistry. 50: 3581-90. PMID 21495621 DOI: 10.1021/Bi101785H |
0.362 |
|
| 2010 |
Palmieri M, Nowell CJ, Condron M, Gardiner J, Holmes AB, Desai J, Burgess AW, Catimel B. Analysis of cellular phosphatidylinositol (3,4,5)-trisphosphate levels and distribution using confocal fluorescent microscopy. Analytical Biochemistry. 406: 41-50. PMID 20599646 DOI: 10.1016/J.Ab.2010.06.033 |
0.343 |
|
| 2009 |
Zhang HH, Walker F, Kiflemariam S, Whitehead RH, Williams D, Phillips WA, Mikeska T, Dobrovic A, Burgess AW. Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B-Raf. International Journal of Cancer. 125: 297-307. PMID 19378335 DOI: 10.1002/Ijc.24289 |
0.313 |
|
| 2009 |
Adams TE, Koziolek EJ, Hoyne PH, Bentley JD, Lu L, Lovrecz G, Ward CW, Lee FT, Scott AM, Nash AD, Rothacker J, Nice EC, Burgess AW, Johns TG. A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo. Growth Factors (Chur, Switzerland). 27: 141-54. PMID 19333814 DOI: 10.1080/08977190902843565 |
0.41 |
|
| 2009 |
Morstyn G, Metcalf D, Burgess A, Fabre JW. Surface antigens on normal and leukaemic human cells detected by monoclonal antibodies. Scandinavian Journal of Haematology. 26: 19-30. PMID 6162194 DOI: 10.1111/J.1600-0609.1981.Tb01619.X |
0.322 |
|
| 2008 |
Clayton AH, Orchard SG, Nice EC, Posner RG, Burgess AW. Predominance of activated EGFR higher-order oligomers on the cell surface. Growth Factors (Chur, Switzerland). 26: 316-24. PMID 18937111 DOI: 10.1080/08977190802442187 |
0.326 |
|
| 2008 |
Burgess AW. EGFR family: Structure physiology signalling and therapeutic target Growth Factors. 26: 263-274. PMID 18800267 DOI: 10.1080/08977190802312844 |
0.31 |
|
| 2007 |
Scott AM, Lee FT, Tebbutt N, Herbertson R, Gill SS, Liu Z, Skrinos E, Murone C, Saunder TH, Chappell B, Papenfuss AT, Poon AM, Hopkins W, Smyth FE, MacGregor D, ... ... Burgess AW, et al. A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors. Proceedings of the National Academy of Sciences of the United States of America. 104: 4071-6. PMID 17360479 DOI: 10.1073/Pnas.0611693104 |
0.35 |
|
| 2007 |
Walker F, Zhang HH, Burgess AW. Identification of a novel EGF-sensitive cell cycle checkpoint Experimental Cell Research. 313: 511-526. PMID 17157295 DOI: 10.1016/J.Yexcr.2006.10.026 |
0.374 |
|
| 2007 |
Gan HK, Walker F, Burgess AW, Rigopoulos A, Scott AM, Johns TG. The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806. The Journal of Biological Chemistry. 282: 2840-50. PMID 17092939 DOI: 10.1074/Jbc.M605136200 |
0.383 |
|
| 2006 |
Ellis AG, Doherty MM, Walker F, Weinstock J, Nerrie M, Vitali A, Murphy R, Johns TG, Scott AM, Levitzki A, McLachlan G, Webster LK, Burgess AW, Nice EC. Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase. Biochemical Pharmacology. 71: 1422-1434. PMID 16522318 DOI: 10.1016/J.Bcp.2006.01.020 |
0.307 |
|
| 2005 |
Lee FT, Mountain AJ, Kelly MP, Hall C, Rigopoulos A, Johns TG, Smyth FE, Brechbiel MW, Nice EC, Burgess AW, Scott AM. Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 7080s-7086s. PMID 16203806 DOI: 10.1158/1078-0432.Ccr-1004-0019 |
0.32 |
|
| 2005 |
Perera RM, Narita Y, Furnari FB, Gan HK, Murone C, Ahlkvist M, Luwor RB, Burgess AW, Stockert E, Jungbluth AA, Old LJ, Cavenee WK, Scott AM, Johns TG. Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6390-9. PMID 16144944 DOI: 10.1158/1078-0432.Ccr-04-2653 |
0.365 |
|
| 2005 |
Johns TG, Mellman I, Cartwright GA, Ritter G, Old LJ, Burgess AW, Scott AM. The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 780-2. PMID 15774576 DOI: 10.1096/Fj.04-1766Fje |
0.37 |
|
| 2005 |
Panousis C, Rayzman VM, Johns TG, Renner C, Liu Z, Cartwright G, Lee FT, Wang D, Gan H, Cao D, Kypridis A, Smyth FE, Brechbiel MW, Burgess AW, Old LJ, et al. Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR. British Journal of Cancer. 92: 1069-77. PMID 15770208 DOI: 10.1038/Sj.Bjc.6602470 |
0.303 |
|
| 2004 |
Luwor RB, Zhu HJ, Walker F, Vitali AA, Perera RM, Burgess AW, Scott AM, Johns TG. The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR. Oncogene. 23: 6095-104. PMID 15221011 DOI: 10.1038/Sj.Onc.1207870 |
0.361 |
|
| 2004 |
Johns TG, Adams TE, Cochran JR, Hall NE, Hoyne PA, Olsen MJ, Kim YS, Rothacker J, Nice EC, Walker F, Ritter G, Jungbluth AA, Old LJ, Ward CW, Burgess AW, et al. Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor. The Journal of Biological Chemistry. 279: 30375-84. PMID 15075331 DOI: 10.1074/Jbc.M401218200 |
0.377 |
|
| 2004 |
Walker F, Orchard SG, Jorissen RN, Hall NE, Zhang HH, Hoyne PA, Adams TE, Johns TG, Ward C, Garrett TP, Zhu HJ, Nerrie M, Scott AM, Nice EC, Burgess AW. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor. The Journal of Biological Chemistry. 279: 22387-98. PMID 15016810 DOI: 10.1074/Jbc.M401244200 |
0.335 |
|
| 2004 |
Faux MC, Ross JL, Meeker C, Johns T, Ji H, Simpson RJ, Layton MJ, Burgess AW. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. Journal of Cell Science. 117: 427-39. PMID 14679305 DOI: 10.1242/Jcs.00862 |
0.348 |
|
| 2004 |
Garrett TPJ, Lou M-, McKern NM, Adams TE, Lovrecz GO, Nice EC, Burgess AW, Ward CW. Structure and signaling in the epidermal growth factor receptor family Acta Crystallographica Section A. 60: 164-164. DOI: 10.1107/S0108767304096758 |
0.31 |
|
| 2003 |
Johns TG, Luwor RB, Murone C, Walker F, Weinstock J, Vitali AA, Perera RM, Jungbluth AA, Stockert E, Old LJ, Nice EC, Burgess AW, Scott AM. Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478. Proceedings of the National Academy of Sciences of the United States of America. 100: 15871-6. PMID 14676326 DOI: 10.1073/Pnas.2036503100 |
0.327 |
|
| 2003 |
Burgess AW, Cho HS, Eigenbrot C, Ferguson KM, Garrett TP, Leahy DJ, Lemmon MA, Sliwkowski MX, Ward CW, Yokoyama S. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Molecular Cell. 12: 541-52. PMID 14527402 DOI: 10.1016/S1097-2765(03)00350-2 |
0.341 |
|
| 2003 |
Zhu HJ, Iaria J, Orchard S, Walker F, Burgess AW. Epidermal growth factor receptor: association of extracellular domain negatively regulates intracellular kinase activation in the absence of ligand. Growth Factors (Chur, Switzerland). 21: 15-30. PMID 12795333 DOI: 10.1080/0897719031000096424 |
0.339 |
|
| 2003 |
Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Experimental Cell Research. 284: 31-53. PMID 12648464 DOI: 10.1016/S0014-4827(02)00098-8 |
0.368 |
|
| 2003 |
Garrett TP, McKern NM, Lou M, Elleman TC, Adams TE, Lovrecz GO, Kofler M, Jorissen RN, Nice EC, Burgess AW, Ward CW. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Molecular Cell. 11: 495-505. PMID 12620236 DOI: 10.1016/S1097-2765(03)00048-0 |
0.312 |
|
| 2002 |
Nheu TV, He H, Hirokawa Y, Tamaki K, Florin L, Schmitz ML, Suzuki-Takahashi I, Jorissen RN, Burgess AW, Nishimura S, Wood J, Maruta H. The K252a derivatives, inhibitors for the PAK/MLK kinase family, selectively block the growth of RAS transformants Cancer Journal. 8: 328-336. PMID 12184411 DOI: 10.1097/00130404-200207000-00009 |
0.304 |
|
| 2002 |
Jorissen RN, Treutlein HR, Epa VC, Burgess AW. Modeling the epidermal growth factor -- epidermal growth factor receptor l2 domain interaction: implications for the ligand binding process. Journal of Biomolecular Structure & Dynamics. 19: 961-72. PMID 12023799 DOI: 10.1080/07391102.2002.10506800 |
0.326 |
|
| 2002 |
Johns TG, Stockert E, Ritter G, Jungbluth AA, Huang HJ, Cavenee WK, Smyth FE, Hall CM, Watson N, Nice EC, Gullick WJ, Old LJ, Burgess AW, Scott AM. Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene. International Journal of Cancer. Journal International Du Cancer. 98: 398-408. PMID 11920591 DOI: 10.1002/Ijc.10189 |
0.357 |
|
| 2001 |
Zhu HJ, Burgess AW. Regulation of transforming growth factor-β signaling Molecular Cell Biology Research Communications. 4: 321-330. PMID 11703090 DOI: 10.1006/Mcbr.2001.0301 |
0.308 |
|
| 2001 |
Nagane M, Narita Y, Mishima K, Levitzki A, Burgess AW, Cavenee WK, Huang HJ. Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor. Journal of Neurosurgery. 95: 472-9. PMID 11565870 DOI: 10.3171/Jns.2001.95.3.0472 |
0.339 |
|
| 2001 |
Elleman TC, Domagala T, McKern NM, Nerrie M, Lönnqvist B, Adams TE, Lewis J, Lovrecz GO, Hoyne PA, Richards KM, Howlett GJ, Rothacker J, Jorissen RN, Lou M, Garrett TP, ... Burgess AW, et al. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain. Biochemistry. 40: 8930-9. PMID 11467954 DOI: 10.1021/Bi010037B |
0.358 |
|
| 2001 |
He H, Levitzki A, Zhu HJ, Walker F, Burgess A, Maruta H. Platelet-derived growth factor requires epidermal growth factor receptor to activate p21-activated kinase family kinases. The Journal of Biological Chemistry. 276: 26741-4. PMID 11356824 DOI: 10.1074/Jbc.C100229200 |
0.363 |
|
| 2001 |
Pouliot N, Nice EC, Burgess AW. Laminin-10 mediates basal and EGF-stimulated motility of human colon carcinoma cells via α 3β 1 and α 6β 4 integrins Experimental Cell Research. 266: 1-10. PMID 11339819 DOI: 10.1006/Excr.2001.5197 |
0.353 |
|
| 2000 |
Pouliot N, Connolly LM, Moritz RL, Simpson RJ, Burgess AW. Colon cancer cells adhesion and spreading on autocrine laminin-10 is mediated by multiple integrin receptors and modulated by EGF receptor stimulation Experimental Cell Research. 261: 360-371. PMID 11112342 DOI: 10.1006/Excr.2000.5065 |
0.37 |
|
| 2000 |
Fridman M, Maruta H, Gonez J, Walker F, Treutlein H, Zeng J, Burgess A. Point Mutants of c-Raf-1 RBD with Elevated Binding to v-Ha-Ras Journal of Biological Chemistry. 275: 30363-30371. PMID 10887184 DOI: 10.1074/Jbc.M003193200 |
0.313 |
|
| 2000 |
Pouliot N, Burgess AW. Multiple autocrine factors including an extracellular matrix protein are required for the proliferation and spreading of human colon carcinoma cells in vitro Growth Factors. 18: 31-49. PMID 10831071 DOI: 10.3109/08977190009003232 |
0.379 |
|
| 2000 |
Domagala T, Konstantopoulos N, Smyth F, Jorissen RN, Fabri L, Geleick D, Lax I, Schlessinger J, Sawyer W, Howlett GJ, Burgess AW, Nice EC. Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptor. Growth Factors (Chur, Switzerland). 18: 11-29. PMID 10831070 DOI: 10.3109/08977190009003231 |
0.321 |
|
| 2000 |
Jorissen RN, Epa VC, Treutlein HR, Garrett TP, Ward CW, Burgess AW. Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor. Protein Science : a Publication of the Protein Society. 9: 310-24. PMID 10716183 DOI: 10.1110/Ps.9.2.310 |
0.306 |
|
| 1998 |
Walker F, Kato A, Gonez LJ, Hibbs ML, Pouliot N, Levitzki A, Burgess AW. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation. Molecular and Cellular Biology. 18: 7192-204. PMID 9819406 DOI: 10.1128/Mcb.18.12.7192 |
0.349 |
|
| 1998 |
Walker F, Hibbs ML, Zhang HH, Gonez LJ, Burgess AW. Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3 Growth Factors Journal. 16: 53-67. PMID 9777370 DOI: 10.3109/08977199809017491 |
0.328 |
|
| 1998 |
Burgess AW. Growth control mechanisms in normal and transformed intestinal cells Philosophical Transactions of the Royal Society B: Biological Sciences. 353: -909. PMID 9684287 DOI: 10.1098/Rstb.1998.0254 |
0.361 |
|
| 1998 |
Moritz RL, Ritter G, Catimel B, Cohen LS, Welt S, Old LJ, Burgess AW, Nice EC, Simpson RJ. Micro-sequencing strategies for the human A33 antigen, a novel surface glycoprotein of human gastrointestinal epithelium. Journal of Chromatography. A. 798: 91-101. PMID 9542130 DOI: 10.1016/S0021-9673(97)01031-5 |
0.302 |
|
| 1997 |
Konstantopoulos N, Burgess A. Growth factors, signalling and cancer. Molecular Medicine Today. 3: 284-285. PMID 9257294 DOI: 10.1016/S1357-4310(97)01075-7 |
0.311 |
|
| 1997 |
Ji H, Moritz RL, Reid GE, Ritter G, Catimel B, Nice E, Heath JK, White SJ, Welt S, Old LJ, Burgess AW, Simpson RJ. Electrophoretic analysis of the novel antigen for the gastrointestinal-specific monoclonal antibody, A33. Electrophoresis. 18: 614-21. PMID 9150949 DOI: 10.1002/Elps.1150180345 |
0.313 |
|
| 1997 |
Heath JK, White SJ, Johnstone CN, Catimel B, Simpson RJ, Moritz RL, Tu GF, Ji H, Whitehead RH, Groenen LC, Scott AM, Ritter G, Cohen L, Welt S, Old LJ, ... ... Burgess AW, et al. The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proceedings of the National Academy of Sciences of the United States of America. 94: 469-74. PMID 9012807 DOI: 10.1073/Pnas.94.2.469 |
0.324 |
|
| 1997 |
Old LJ, Welt S, Ritter G, Simpson RJ, Nice E, Moritz RL, Catimel B, Ji H, Burgess A, Heath J, White S, Johnston C. Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides Biofutur. 1997: 46. DOI: 10.1016/S0294-3506(99)80328-7 |
0.323 |
|
| 1997 |
Nice E, Catimel B, Lackmann M, Stacker S, Runting A, Wilks A, Nicola N, Burgess A. Strategies for the identification and purification of ligands for orphan biomolecules Letters in Peptide Science. 4: 107-120. DOI: 10.1007/Bf02443522 |
0.326 |
|
| 1996 |
Catimel B, Ritter G, Welt S, Old LJ, Cohen L, Nerrie MA, White SJ, Heath JK, Demediuk B, Domagala T, Lee FT, Scott AM, Tu GF, Ji H, Moritz RL, ... ... Burgess AW, et al. Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epithelium. The Journal of Biological Chemistry. 271: 25664-70. PMID 8810343 DOI: 10.1074/Jbc.271.41.25664 |
0.31 |
|
| 1995 |
Davis ID, Treutlein HR, Friedrich K, Burgess AW. A potent human interleukin-4 antagonist stimulates the proliferation of murine cells expressing the human interleukin-4 binding chain. Growth Factors Journal. 12: 69-83. PMID 8527165 DOI: 10.3109/08977199509003215 |
0.332 |
|
| 1995 |
Zhang Q, Walker F, Burgess AW, Baldwin GS. Reduction in platelet-derived growth factor receptor mRNA in v-src-transformed fibroblasts Biochimica Et Biophysica Acta. 1266: 9-15. PMID 7718626 DOI: 10.1016/0167-4889(94)00232-4 |
0.349 |
|
| 1994 |
Groenen LC, Nice EC, Burgess AW. Structure-Function relationships for the EGF/TGF-α family of mitogens Growth Factors Journal. 11: 235-257. PMID 7779404 DOI: 10.3109/08977199409010997 |
0.335 |
|
| 1993 |
Nice E, Layton J, Fabri L, Hellman U, Engstrom A, Persson B, Burgess AW. Mapping of the antibody- and receptor-binding domains of granulocyte colony-stimulating factor using and optical biosensor Comparison with enzyme-linked immunosorbent assay competition studies Journal of Chromatography A. 646: 159-168. PMID 7691860 DOI: 10.1016/S0021-9673(99)87017-4 |
0.304 |
|
| 1992 |
Sizeland AM, Burgess AW. Anti-sense transforming growth factor α oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line Molecular Biology of the Cell. 3: 1235-1243. PMID 1457828 DOI: 10.1091/Mbc.3.11.1235 |
0.386 |
|
| 1992 |
Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony- stimulating factor (first of two parts) New England Journal of Medicine. 327: 28-35. PMID 1375975 DOI: 10.1056/Nejm199207023270106 |
0.33 |
|
| 1991 |
Walker F, Nice E, Fabri L, Moy FJ, Liu JF, Wu R, Scheraga HA, Burgess AW. Resistance to receptor-mediated degradation of a murine epidermal growth factor analogue (EGF-Val-47) potentiates its mitogenic activity. Biochemistry. 29: 10635-40. PMID 2271672 DOI: 10.1021/Bi00499A009 |
0.353 |
|
| 1991 |
Sizeland AM, Burgess AW. The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors Molecular and Cellular Biology. 11: 4005-4014. PMID 2072905 DOI: 10.1128/mcb.11.8.4005-4014.1991 |
0.378 |
|
| 1991 |
Sizeland A, Bol S, Burgess AW. The action of epidermal growth factor (EGF) is limited to specific phases of the cell cycle in an EGF dependent colonic cell line Growth Factors. 4: 129-143. PMID 2049180 DOI: 10.3109/08977199109000264 |
0.329 |
|
| 1991 |
Heyworth CM, Hampson J, Dexter TM, Walker F, Burgess AW, Kan O, Cook N, Vallance SJ, Whetton AD. Development of multipotential haemopoietic stem cells to neutrophils is associated with increased expression of receptors for granulocyte macrophage colony-stimulating factor: altered biological responses to GM-CSF during development. Growth Factors Journal. 5: 87-98. PMID 1837466 DOI: 10.3109/08977199109000274 |
0.35 |
|
| 1991 |
Cebon J, Burgess AW, 洋 供, 史子 加. Glycosylation of Human Granulocyte-Macrophage Colony Stimulating Factor Alters Receptor Binding and Biological Activity Trends in Glycoscience and Glycotechnology. 3: 266-274. DOI: 10.4052/Tigg.3.266 |
0.333 |
|
| 1990 |
Whitehead RH, Nice EC, Lloyd CJ, James R, Burgess AW. Detection of colonic growth factors using a human colonic carcinoma cell line (LIM 1215) International Journal of Cancer. 46: 858-863. PMID 2228314 DOI: 10.1002/Ijc.2910460518 |
0.358 |
|
| 1990 |
Lang RA, Burgess AW. Autocrine growth factors and tumourigenic transformation Immunology Today. 11: 244-249. PMID 2201310 DOI: 10.1016/0167-5699(90)90098-T |
0.316 |
|
| 1990 |
Dempsey PJ, Layton JE, Duhrsen U, Nicola NA, Cebon J, Burgess AW, Morstyn G. Monoclonal antibodies that recognize human granulocyte-macrophage colony-stimulating factor and neutralize its bioactivity in vitro. Hybridoma. 9: 545-58. PMID 1706312 DOI: 10.1089/Hyb.1990.9.545 |
0.314 |
|
| 1990 |
Nice E, Dempsey P, Layton J, Morstyn G, Cup DF, Simpson R, Fabri L, Burgess A. Human granulocyte-macrophage colony-stimulating factor (hGM-CSF): identification of a binding site for a neutralizing antibody. Growth Factors Journal. 3: 159-169. PMID 1698402 DOI: 10.3109/08977199009108278 |
0.31 |
|
| 1989 |
Stanley IJ, Nicola NA, Burgess AW. Growth factor-induced phosphorylation of c-ras p21 in normal hemopoietic progenitor cells. Growth Factors (Chur, Switzerland). 2: 53-9. PMID 2699569 DOI: 10.3109/08977198909069081 |
0.312 |
|
| 1989 |
Böuhmer RM, Burgess AW. An autocrine activity capable of substituting for serum in cell cultures Growth Factors. 1: 347-356. PMID 2699433 DOI: 10.3109/08977198909000258 |
0.359 |
|
| 1989 |
Burgess AW. Epidermal growth factor and transforming growth factor α British Medical Bulletin. 45: 401-424. PMID 2688814 DOI: 10.1093/Oxfordjournals.Bmb.A072331 |
0.326 |
|
| 1988 |
Walker F, Burgess AW. Transmodulation of the epidermal-growth-factor receptor in permeabilized 3T3 cells Biochemical Journal. 256: 109-115. PMID 3265618 DOI: 10.1042/Bj2560109 |
0.367 |
|
| 1988 |
Burgess AW, Lloyd CJ, Smith S, Stanley E, Walker F, Fabri L, Simpson RJ, Nice EC. Murine epidermal growth factor: structure and function. Biochemistry. 27: 4977-85. PMID 3262370 DOI: 10.1021/Bi00414A005 |
0.321 |
|
| 1988 |
Burgess AW. Cell surface heparan sulphate implicated in haemopoietic growth factor signalling Immunology Today. 9: 267-268. PMID 2978375 DOI: 10.1016/0167-5699(88)91307-2 |
0.324 |
|
| 1988 |
Bohmer RM, Burgess AW. Granulocytic colony-stimulating factor (G-CSF) does not induce differentiation of WEHI3B(D+) cells but is required for the survival of the mature progeny International Journal of Cancer. 42: 53-58. PMID 2455692 DOI: 10.1002/Ijc.2910420111 |
0.321 |
|
| 1988 |
Hamilton JA, Vairo G, Nicola NA, Burgess A, Metcalf D, Lingelbach SR. Activation and proliferation signals in murine macrophages: synergistic interactions between the hematopoietic growth factors and with phorbol ester for DNA synthesis Blood. 71: 1574-1580. DOI: 10.1182/Blood.V71.6.1574.Bloodjournal7161574 |
0.306 |
|
| 1987 |
Walker F, Burgess AW. Internalisation and recycling of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on a murine myelomonocytic leukemia Journal of Cellular Physiology. 130: 255-261. PMID 3546340 DOI: 10.1002/Jcp.1041300211 |
0.363 |
|
| 1987 |
Burgess AW. Growth factors and their receptors: specific roles in development Bioessays. 6: 79-81. PMID 3032168 DOI: 10.1002/Bies.950060210 |
0.324 |
|
| 1987 |
Burgess A, Begley C, Johnson G, Lopez A, Williamson D, Mermod J, Simpson R, Schmitz A, DeLamarter J. Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor Blood. 69: 43-51. DOI: 10.1182/Blood.V69.1.43.Bloodjournal69143 |
0.311 |
|
| 1986 |
Burgess AW. The control of blood cell production Immunology Today. 7: 351-352. PMID 25291321 DOI: 10.1016/0167-5699(86)90015-0 |
0.301 |
|
| 1986 |
Gardner ID, Whitehead RH, Burgess AW. Production and characterization of monoclonal antibodies reactive with subsets of epidermal cells Pathology. 18: 313-320. PMID 3785981 DOI: 10.3109/00313028609059483 |
0.337 |
|
| 1986 |
Metcalf D, Burgess AW, Johnson GR, Nicola NA, Nice EC, Delamarter J, Thatcher DR, Mermod J-. In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF. Journal of Cellular Physiology. 128: 421-431. PMID 3528176 DOI: 10.1002/Jcp.1041280311 |
0.331 |
|
| 1986 |
Montelione GT, Wüthrich K, Nice EC, Burgess AW, Scheraga HA. Identification of two anti-parallel beta-sheet conformations in the solution structure of murine epidermal growth factor by proton magnetic resonance. Proceedings of the National Academy of Sciences of the United States of America. 83: 8594-8. PMID 3490668 DOI: 10.1073/Pnas.83.22.8594 |
0.321 |
|
| 1986 |
Burgess AW, Metcalf D, Sparrow LG, Simpson RJ, Nice EC. Granulocyte/macrophage colony-stimulating factor from mouse lung conditioned medium. Purification of multiple forms and radioiodination. Biochemical Journal. 235: 805-814. PMID 3489462 DOI: 10.1042/Bj2350805 |
0.319 |
|
| 1986 |
Burgess AW. Growth factors, receptors and cancer Bioessays. 5: 15-18. PMID 3024639 DOI: 10.1002/Bies.950050105 |
0.326 |
|
| 1986 |
Chatelier RC, Ashcroft RG, Lloyd CJ, Nice EC, Whitehead RH, Sawyer WH, Burgess AW. Binding of fluoresceinated epidermal growth factor to A431 cell sub-populations studied using a model-independent analysis of flow cytometric fluorescence data. The Embo Journal. 5: 1181-1186. DOI: 10.1002/J.1460-2075.1986.Tb04344.X |
0.329 |
|
| 1985 |
Burgess AW, Nice EC. [43] Murine granulocyte-macrophage colony-stimulating factor Methods in Enzymology. 116: 588-600. PMID 3878927 DOI: 10.1016/S0076-6879(85)16045-3 |
0.351 |
|
| 1985 |
Simpson RJ, Smith JA, Moritz RL, O'Hare MJ, Rudland PS, Morrison JR, Lloyd CJ, Grego B, Burgess AW, Nice EC. Rat epidermal growth factor: complete amino acid sequence. Homology with the corresponding murine and human proteins; isolation of a form truncated at both ends with full in vitro biological activity. European Journal of Biochemistry / Febs. 153: 629-37. PMID 3000782 DOI: 10.1111/J.1432-1033.1985.Tb09346.X |
0.336 |
|
| 1985 |
Walker F, Nicola NA, Metcalf D, Burgess AW. Hierarchical down-modulation of hemopoietic growth factor receptors Cell. 43: 269-276. PMID 3000602 DOI: 10.1016/0092-8674(85)90032-7 |
0.337 |
|
| 1985 |
Burgess AW. Growth factors and cancer Australian and New Zealand Journal of Surgery. 55: 105-110. PMID 2994617 DOI: 10.1111/J.1445-2197.1985.Tb00868.X |
0.387 |
|
| 1985 |
Cook WD, Metcalf D, Nicola NA, Burgess AW, Walker F. Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell. 41: 677-83. PMID 2988782 DOI: 10.1016/S0092-8674(85)80048-9 |
0.369 |
|
| 1985 |
Burgess A. Growth factors and oncogenes Immunology Today. 6: 107-112. DOI: 10.1016/0167-5699(85)90026-X |
0.345 |
|
| 1985 |
Walker F, Burgess AW. Specific binding of radioiodinated granulocyte-macrophage colony-stimulating factor to hemopoietic cells. The Embo Journal. 4: 933-939. DOI: 10.1002/J.1460-2075.1985.Tb03721.X |
0.343 |
|
| 1984 |
Gough NM, Gough J, Metcalf D, Kelso A, Grail D, Nicola NA, Burgess AW, Dunn AR. Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte - Macrophage colony stimulating factor Nature. 309: 763-767. PMID 6610831 DOI: 10.1038/309763A0 |
0.322 |
|
| 1984 |
Cooper PC, Burgess AW. Electrophoretic analysis of the cytoplasmic and nuclear protein changes after induction of differentiation in WEHI-3B myelomonocytic leukemia cells Journal of Cellular Biochemistry. 25: 161-182. PMID 6332817 DOI: 10.1002/Jcb.240250305 |
0.306 |
|
| 1984 |
Burgess AW. The complex mediators of cell growth and differentiation Immunology Today. 5: 155-158. DOI: 10.1016/0167-5699(84)90001-X |
0.386 |
|
| 1983 |
Stanley IJ, Burgess AW. Granulocyte macrophage-colony stimulating factor stimulates the synthesis of membrane and nuclear proteins in murine neutrophils. Journal of Cellular Biochemistry. 23: 241-58. PMID 6609926 DOI: 10.1002/Jcb.240230121 |
0.32 |
|
| 1983 |
Burgess AW, Cooper PC, Stanley IJ, Nicola NA. Effect of colony-stimulating factors on the proteins synthesized by normal and leukemic myeloid progenitor cells. Haematology and Blood Transfusion. 28: 338-44. PMID 6602739 DOI: 10.1007/978-3-642-68761-7_64 |
0.354 |
|
| 1983 |
Burgess A, Nicola N. Effects of 12-0-tetradecanoylphorbol-13-acetate (TPA) on the proliferation of granulocyte-macrophage colony-forming cells. Blood. 61: 575-579. DOI: 10.1182/Blood.V61.3.575.Bloodjournal613575 |
0.346 |
|
| 1982 |
Burgess AW, Knesel J, Sparrow LG, Nicola NA, Nice EC. Two forms of murine epidermal growth factor: Rapid separation by using reverse-phase HPLC Proceedings of the National Academy of Sciences of the United States of America. 79: 5753-5757. PMID 6985267 DOI: 10.1073/Pnas.79.19.5753 |
0.329 |
|
| 1982 |
Metcalf D, Burgess AW. Clonal analysis of progenitor cell commitment to granulocyte or macrophage production Journal of Cellular Physiology. 111: 275-283. PMID 6980223 DOI: 10.1002/Jcp.1041110308 |
0.308 |
|
| 1982 |
Cooper PC, Metcalf D, Burgess AW. Biochemical and functional characterization of mature progeny purified from a myelomonocytic leukemia cell line Leukemia Research. 6: 313-327. PMID 6956783 DOI: 10.1016/0145-2126(82)90093-5 |
0.342 |
|
| 1982 |
Baldwin GS, Burgess AW, Kemp BE. Phosphorylation of a synthetic gastrin peptide by the tyrosine kinase of A431 cell membranes Biochemical and Biophysical Research Communications. 109: 656-663. PMID 6891588 DOI: 10.1016/0006-291X(82)91990-8 |
0.313 |
|
| 1982 |
Burgess AW, Nicola NA, Johnson GR, Nice EC. Colony-Forming Cell Proliferation: A Rapid and Sensitive Assay System for Murine Granulocyte and Macrophage Colony-Stimulating Factors Blood. 60: 1219-1223. DOI: 10.1182/Blood.V60.5.1219.1219 |
0.329 |
|
| 1981 |
Nicola N, Metcalf D, Melchner Hv, Burgess A. Isolation of murine fetal hemopoietic progenitor cells and selective fractionation of various erythroid precursors. Blood. 58: 376-386. DOI: 10.1182/Blood.V58.2.376.376 |
0.334 |
|
| 1980 |
Nicola NA, Burgess AW, Staber FG, Johnson GR, Metcalf D, Battye FL. Differential expression of lectin receptors during hemopoietic differntiation: Enrichment for granulocyte‐macrophage progenitor cells Journal of Cellular Physiology. 103: 217-237. PMID 7440634 DOI: 10.1002/Jcp.1041030207 |
0.331 |
|
| 1980 |
Burgess AW, Metcalf D. Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemic cells International Journal of Cancer. 26: 647-654. PMID 6972358 DOI: 10.1002/Ijc.2910260517 |
0.347 |
|
| 1980 |
Burgess AW, Metcalf D, Russell SHM, Nicola NA. Granulocyte/macrophage-, megakaryocyte-, eosinophil- and erythroid-colony-stimulating factors produced by mouse spleen cells. Biochemical Journal. 185: 301-314. PMID 6967311 DOI: 10.1042/Bj1850301 |
0.335 |
|
| 1980 |
Williams N, Burgess AW. The effect of mouse lung granulocyte-macrophage colony-stimulating factor and other colony-stimulating activities on the proliferation and differentiation of murine bone marrow cells in long-term cultures Journal of Cellular Physiology. 102: 287-295. PMID 6967069 DOI: 10.1002/Jcp.1041020303 |
0.31 |
|
| 1980 |
Staber FG, Burgess AW. Serum of lipopolysaccharide-treated mice contains two types of colony-stimulating factor, separable by affinity chromatography Journal of Cellular Physiology. 102: 1-10. PMID 6966284 DOI: 10.1002/Jcp.1041020102 |
0.306 |
|
| 1980 |
Burgess A, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood. 56: 947-958. DOI: 10.1182/Blood.V56.6.947.Bloodjournal566947 |
0.352 |
|
| 1980 |
Metcalf D, Johnson G, Burgess A. Direct stimulation by purified GM-CSF of the proliferation of multipotential and erythroid precursor cells. Blood. 55: 138-147. DOI: 10.1182/Blood.V55.1.138.Bloodjournal551138 |
0.332 |
|
| 1979 |
Howard M, Burgess A, McPhee D, Metcalf D. T-cell hybridoma secreting hemopoietic regulatory molecules: Granulocyte-macrophage and eosinophil colony-stimulating factors Cell. 18: 993-999. PMID 316364 DOI: 10.1016/0092-8674(79)90211-3 |
0.349 |
|
| 1979 |
Watt SM, Burgess AW, Metcalf D. Isolation and surface labeling of murine polymorphonuclear neutrophils Journal of Cellular Physiology. 100: 1-22. PMID 313932 DOI: 10.1002/Jcp.1041000102 |
0.306 |
|
| 1979 |
Nicola N, Metcalf D, Johnson G, Burgess A. Separation of functionally distinct human granulocyte-macrophage colony-stimulating factors. Blood. 54: 614-627. DOI: 10.1182/Blood.V54.3.614.614 |
0.314 |
|
| 1978 |
Nicola NA, Burgess AW, Metcalf D, Battye FL. Separation of mouse bone marrow cells using wheat germ agglutinin affinity chromatography Australian Journal of Experimental Biology and Medical Science. 56: 663-679. PMID 752308 DOI: 10.1038/Icb.1978.74 |
0.333 |
|
| 1978 |
Burgess AW, Metcalf D, Watt SM. Regulation of hemopoietic cell differentiation and proliferation Journal of Supramolecular and Cellular Biochemistry. 8: 489-500. PMID 309973 DOI: 10.1002/Jss.400080411 |
0.383 |
|
| 1978 |
Johnson GR, Burgess AW. Molecular and biological properties of a macrophage colony-stimulating factor from mouse yolk sacs Journal of Cell Biology. 77: 35-47. PMID 307001 DOI: 10.1083/Jcb.77.1.35 |
0.304 |
|
| 1978 |
Nicola NA, Metcalf D, Johnson GR, Burgess AW. Preparation of colony stimulating factors from human placental conditioned medium Leukemia Research. 2: 313-322. DOI: 10.1016/0145-2126(78)90018-8 |
0.314 |
|
| 1977 |
Claesson MH, Whittingham S, Rodger MB, Burgess AW. Colony growth of human T lymphocytes in agar: effect of a soluble factor from adherent cells European Journal of Immunology. 7: 608-612. PMID 303567 DOI: 10.1002/Eji.1830070906 |
0.342 |
|
| 1977 |
Burgess AW, Metcalf D. The effect of colony stimulating factor on the synthesis of ribonucleic acid by mouse bone marrow cells in vitro Journal of Cellular Physiology. 90: 471-483. PMID 300739 DOI: 10.1002/Jcp.1040900311 |
0.307 |
|
| 1977 |
Burgess A, Wilson E, Metcalf D. Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells Blood. 49: 573-583. DOI: 10.1182/Blood.V49.4.573.573 |
0.324 |
|
| Show low-probability matches. |